Definitive Healthcare EPS DH
Diluted earnings per share by quarter and over the last twelve months, from 2021.
- Last 12 months, to Jun 30, 2026
- −$1.60
- Latest quarter, Q2 FY26
- −$0.05
- Fiscal year 2025
- −$1.25
Definitive Healthcare's earnings per share was −$1.60 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was −$0.05.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$1.25 | n/a |
| FY2024 | −$3.52 | n/a |
| FY2023 | −$1.78 | n/a |
| FY2022 | −$0.12 | n/a |
| FY2021 | n/a | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$0.05 | n/a | −$1.60 | |
| Q1 FY26 | −$1.32 | n/a | −$1.62 | |
| Q4 FY25 | −$0.09 | n/a | −$1.25 | |
| Q3 FY25 | −$0.14 | n/a | −$1.67 | |
| Q2 FY25 | −$0.07 | n/a | −$2.65 | |
| Q1 FY25 | −$0.95 | n/a | −$4.39 | |
| Q4 FY24 | −$0.51 | n/a | −$3.52 | |
| Q3 FY24 | −$1.12 | n/a | −$3.10 | |
| Q2 FY24 | −$1.81 | n/a | −$3.48 | |
| Q1 FY24 | −$0.08 | n/a | −$1.75 | |
| Q4 FY23 | −$0.09 | −250% | −$1.78 | |
| Q3 FY23 | −$1.50 | n/a | −$1.63 |
Against its peers
Companies in Software - Infrastructure nearest Definitive Healthcare's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| DHDefinitive Healthcare | −$1.60 | |
| NTWKNetsol Technologies | $0.25 | +2% a year |
| EGANEGAIN | $0.32 | −72% a year |
| FATNFatpipe | $0.39 | +144% a year |
| CCLDCareCloud | $0.07 | |
| WFCFWhere Food Comes From | $0.28 | −30% a year |
| MKLYMcKinley Acquisition | $0.34 | |
| RBBNRibbon Communications | $0.08 | |
| IDNIntellicheck | $0.15 | |
| MKTWMarketwise | $0.87 | −70% a year |
| IIIVi3 Verticals | $0.32 | +10% a year |
| Peer median | $0.30 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Definitive Healthcare
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.